Yuanjun Lu

2.1k total citations · 2 hit papers
40 papers, 1.5k citations indexed

About

Yuanjun Lu is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Yuanjun Lu has authored 40 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 12 papers in Oncology and 11 papers in Immunology. Recurrent topics in Yuanjun Lu's work include Immune cells in cancer (7 papers), MicroRNA in disease regulation (6 papers) and Ferroptosis and cancer prognosis (5 papers). Yuanjun Lu is often cited by papers focused on Immune cells in cancer (7 papers), MicroRNA in disease regulation (6 papers) and Ferroptosis and cancer prognosis (5 papers). Yuanjun Lu collaborates with scholars based in Hong Kong, China and United States. Yuanjun Lu's co-authors include Ning Wang, Yibin Feng, Yau-Tuen Chan, Hor‐Yue Tan, Sha Li, Cheng Zhang, Jian Ma, Zailong Qin, Guiyuan Li and Lingyu Wei and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Journal of Power Sources.

In The Last Decade

Yuanjun Lu

38 papers receiving 1.5k citations

Hit Papers

Epigenetic regulation in human cancer: the potential role... 2020 2026 2022 2024 2020 2022 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Epigenetic regulation in human cancer: the potential role of epi-drug in cancer therapy
    2020 329 citations Yuanjun Lu, Yau-Tuen Chan et al. profile →
  2. Epigenetic regulation of ferroptosis via ETS1/miR-23a-3p/ACSL4 axis mediates sorafenib resistance in human hepatocellular carcinoma
    2022 145 citations Yuanjun Lu, Yau-Tuen Chan et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuanjun Lu Hong Kong 22 849 496 360 225 215 40 1.5k
Haiyang Guo China 23 832 1.0× 399 0.8× 267 0.7× 122 0.5× 170 0.8× 58 1.5k
Qingyuan Yang China 25 806 0.9× 242 0.5× 196 0.5× 191 0.8× 175 0.8× 53 1.4k
В Ф Чехун Ukraine 17 1.2k 1.4× 717 1.4× 503 1.4× 149 0.7× 186 0.9× 156 2.0k
Luyi Huang China 21 979 1.2× 415 0.8× 112 0.3× 166 0.7× 74 0.3× 45 1.5k
Martina Raudenská Czechia 22 862 1.0× 438 0.9× 477 1.3× 209 0.9× 209 1.0× 69 1.9k
Francisco Javier Rodrı́guez-Berrocal Spain 22 677 0.8× 203 0.4× 442 1.2× 123 0.5× 203 0.9× 61 1.4k
Christophe Deben Belgium 20 652 0.8× 301 0.6× 617 1.7× 255 1.1× 240 1.1× 49 1.5k
Yuanxiang Wang China 28 1.3k 1.5× 285 0.6× 381 1.1× 130 0.6× 305 1.4× 86 2.2k
Joan Chang United Kingdom 20 683 0.8× 222 0.4× 329 0.9× 179 0.8× 103 0.5× 33 1.5k
Mariarosaria Conte Italy 22 1.1k 1.3× 167 0.3× 287 0.8× 84 0.4× 141 0.7× 50 1.6k

Countries citing papers authored by Yuanjun Lu

Since Specialization
Citations

This map shows the geographic impact of Yuanjun Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuanjun Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuanjun Lu more than expected).

Fields of papers citing papers by Yuanjun Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuanjun Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuanjun Lu. The network helps show where Yuanjun Lu may publish in the future.

Co-authorship network of co-authors of Yuanjun Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Yuanjun Lu. A scholar is included among the top collaborators of Yuanjun Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuanjun Lu. Yuanjun Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lu, Yuanjun, et al.. (2025). Cancer-associated fibroblasts: central players in cancer hallmarks and therapeutic resistance. Cell Communication and Signaling. 23(1). 534–534.
2.
Feng, Zixin, Yau-Tuen Chan, Yuanjun Lu, et al.. (2024). Siwu decoction suppress myeloid-derived suppressor cells through tumour cells necroptosis to inhibit hepatocellular carcinoma. Phytomedicine. 133. 155913–155913. 8 indexed citations
3.
Lu, Yuanjun, Junyu Wu, Lin Xu, et al.. (2024). Osteoprotegerin mediates adipogenesis in obesity. Journal of Advanced Research. 62. 245–255. 5 indexed citations
4.
Wu, Junyu, Yau-Tuen Chan, Yuanjun Lu, et al.. (2023). Genipin-activating PPARγ impedes CCR2-mediated macrophage infiltration into postoperative liver to suppress recurrence of hepatocellular carcinoma. International Journal of Biological Sciences. 19(16). 5257–5274. 6 indexed citations
5.
Li, Lanzhou, Chunyue Wang, Qiucheng Li, et al.. (2023). Exosomes as a modulator of immune resistance in human cancers. Cytokine & Growth Factor Reviews. 73. 135–149. 15 indexed citations
6.
Chan, Yau-Tuen, Hor‐Yue Tan, Yuanjun Lu, et al.. (2023). Pancreatic melatonin enhances anti-tumor immunity in pancreatic adenocarcinoma through regulating tumor-associated neutrophils infiltration and NETosis. Acta Pharmaceutica Sinica B. 13(4). 1554–1567. 29 indexed citations
7.
8.
Chen, Guo-Ming, Xiangjun Qi, Yang Luo, et al.. (2023). Characterization of cuproptosis in gastric cancer and relationship with clinical and drug reactions. Frontiers in Cell and Developmental Biology. 11. 1172895–1172895. 8 indexed citations
9.
Zhang, Cheng, Guoming Chen, Guoyi Tang, et al.. (2023). Multi-component Chinese medicine formulas for drug discovery: State of the art and future perspectives. SHILAP Revista de lepidopterología. 2(1). 45 indexed citations
10.
11.
Chen, Feiyu, Zhangfeng Zhong, Cheng Zhang, et al.. (2022). Potential Focal Adhesion Kinase Inhibitors in Management of Cancer: Therapeutic Opportunities from Herbal Medicine. International Journal of Molecular Sciences. 23(21). 13334–13334. 4 indexed citations
12.
Lu, Yuanjun, et al.. (2022). The Role and Mechanisms of Selenium Supplementation on Fatty Liver-Associated Disorder. Antioxidants. 11(5). 922–922. 31 indexed citations
13.
Chan, Yau-Tuen, Yuanjun Lu, Junyu Wu, et al.. (2022). CRISPR-Cas9 library screening approach for anti-cancer drug discovery: overview and perspectives. Theranostics. 12(7). 3329–3344. 57 indexed citations
14.
Wu, Junyu, Yuanjun Lu, Yau-Tuen Chan, et al.. (2022). Circulating tumor cells in the early detection of human cancers. International Journal of Biological Sciences. 18(8). 3251–3265. 40 indexed citations
15.
Wang, Ning, Hor‐Yue Tan, Yuanjun Lu, et al.. (2021). PIWIL1 governs the crosstalk of cancer cell metabolism and immunosuppressive microenvironment in hepatocellular carcinoma. Signal Transduction and Targeted Therapy. 6(1). 86–86. 44 indexed citations
16.
Yuan, Hongchao, Yuanjun Lu, Yau-Tuen Chan, et al.. (2021). The Role of Protein SUMOylation in Human Hepatocellular Carcinoma: A Potential Target of New Drug Discovery and Development. Cancers. 13(22). 5700–5700. 16 indexed citations
17.
Chan, Yau-Tuen, Ning Wang, Hor‐Yue Tan, et al.. (2021). Systematic Review with Meta-Analysis: Effectiveness and Safety of Acupuncture as Adjuvant Therapy for Side Effects Management in Drug Therapy-Receiving Breast Cancer Patients. Evidence-based Complementary and Alternative Medicine. 2021. 1–15. 5 indexed citations
18.
Gooya, Ali, et al.. (2019). Bayesian Polytrees With Learned Deep Features for Multi-Class Cell Segmentation. IEEE Transactions on Image Processing. 28(7). 3246–3260. 16 indexed citations
19.
Zhang, Xuemei, Lingyu Wei, Jing Wang, et al.. (2017). Suppression Colitis and Colitis-Associated Colon Cancer by Anti-S100a9 Antibody in Mice. Frontiers in Immunology. 8. 1774–1774. 73 indexed citations
20.
Lu, Yuanjun, Bryan E. G. Lucier, Yue Zhang, et al.. (2017). Sizable dynamics in small pores: CO2location and motion in the α-Mg formate metal–organic framework. Physical Chemistry Chemical Physics. 19(8). 6130–6141. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Haiyang Guo Breakdown of academic impact, for papers by Qingyuan Yang Breakdown of academic impact, for papers by В Ф Чехун Breakdown of academic impact, for papers by Luyi Huang Breakdown of academic impact, for papers by Martina Raudenská Breakdown of academic impact, for papers by Francisco Javier Rodrı́guez-Berrocal Breakdown of academic impact, for papers by Christophe Deben Breakdown of academic impact, for papers by Yuanxiang Wang Breakdown of academic impact, for papers by Joan Chang Breakdown of academic impact, for papers by Mariarosaria Conte
Rankless by CCL
2026